Physician profile
John Feder
NPI 1558360081
$1,190.57
in general payments reported to CMS, 2019-2025
11 companies · $357 in 2025
The $357 reported for 2025 was less than what a typical Foot and Ankle Surgery provider received nationally (typical 2025 total: $1,200).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $204 · 2020: $19.98 · 2021: $85.41 · 2022: $318 · 2023: $207 · 2025: $357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $563.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $563.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Djo, LLC | $356.22 | 2021-2025 | Cmf |
| Stryker Corporation | $339.20 | 2025 | Citrefix, Hoffmann, Sonicanchor |
| Integra Lifesciences Corporation | $149.40 | 2022 | |
| Wright Medical Technology, INC. | $105.48 | 2019 | |
| Curvebeam LLC | $74.14 | 2023 | |
| Stimwave Technologies Incorporated | $50.00 | 2019 | |
| Atricure, INC. | $47.64 | 2023 | |
| Dynasplint Systems INC. | $24.93 | 2019 | |
| Baxter Healthcare | $23.58 | 2019 | |
| Acelrx Pharmaceuticals, INC. | $19.98 | 2020 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$132.12 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Feder listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.